ciprofloxacin has been researched along with floxacillin in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (30.77) | 18.2507 |
| 2000's | 10 (38.46) | 29.6817 |
| 2010's | 7 (26.92) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Duewelhenke, N; Eysel, P; Krut, O | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bowyer, GW; Cumberland, N | 1 |
| Chadwick, PR; Thomas, NB | 1 |
| Bodsworth, NJ; Nelson, MJ; Price, R | 1 |
| Pulverer, G; Rump, A; Schierholz, JM | 1 |
| Berkels, R; Pulverer, G; Rump, AF; Schierholz, JM; Steinhauser, H | 1 |
| Entenza, JM; Glauser, MP; Moreillon, P; Vouillamoz, J | 2 |
| Degener, JE; Kosterink, JG; Mulder, JG | 1 |
| Blatter, M; Frei, R; Ochsner, PE; Widmer, AF; Zimmerli, W | 1 |
| Banky, JP; Ostergaard, L; Spelman, D | 1 |
| Lloyd, D; Smith, D | 1 |
| Ratjen, F | 1 |
| Hartung, T; Laskay, T; Lotz, S; Morath, S; Solbach, W; Starke, A; Ziemann, C | 1 |
| Boyle, JR; Chaudhuri, A; Gaunt, ME; Hayes, PD; Sadat, U; Varty, K | 1 |
| Harding, KG; Hill, KE; Malic, S; McKee, R; Rennison, T; Thomas, DW; Williams, DW | 1 |
| Moviat, M; Popa, C; Wever, PC | 1 |
| Ahmed, SS; Akhtaruzzaman, SM; Anwar, KS; Khan, MA; Salam, MA; Siddiqui, MA | 1 |
| Bowler, IC; Buchanan, R; Crook, D; Stoesser, N | 1 |
| Butcher, J; Hansom, D; Kean, R; Mackay, WG; Ramage, G; Sherry, L; Townsend, EM; Williams, C | 1 |
| Brüggemann, RJM; Gompelman, M; Jager, NGL; Korzilius, JW; Rovers, CP; Wanten, GJA; Wezendonk, GTJ | 1 |
1 review(s) available for ciprofloxacin and floxacillin
| Article | Year |
|---|---|
Chronic relapsing salmonella osteomyelitis in an immunocompetent patient: case report and literature review.
Topics: Adult; Anti-Infective Agents; Cefazolin; Ceftriaxone; Cephalosporins; Chronic Disease; Ciprofloxacin; Drug Therapy, Combination; Floxacillin; Humans; Immunocompetence; Male; Osteomyelitis; Penicillins; Recurrence; Salmonella; Salmonella Infections; Time Factors | 2002 |
1 trial(s) available for ciprofloxacin and floxacillin
| Article | Year |
|---|---|
Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; Floxacillin; Hip Prosthesis; Humans; Knee Prosthesis; Male; Middle Aged; Orthopedic Fixation Devices; Penicillins; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin | 1998 |
24 other study(ies) available for ciprofloxacin and floxacillin
| Article | Year |
|---|---|
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Antibiotic release from impregnated pellets and beads.
Topics: Amoxicillin; Anti-Bacterial Agents; Biological Assay; Calcium Sulfate; Ciprofloxacin; Drug Carriers; Floxacillin; Gentamicins; Imipenem; In Vitro Techniques; Methylmethacrylates; Penicillin G | 1994 |
Conservative management of a patient with bilateral renal abscesses.
Topics: Abscess; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Escherichia coli Infections; Floxacillin; Humans; Kidney Diseases; Male; Middle Aged; Ultrasonography | 1994 |
A case of gonococcal mastitis in a male.
Topics: Adult; Ciprofloxacin; Floxacillin; Gonorrhea; Homosexuality; Humans; Male; Mastitis; Neisseria gonorrhoeae; Sexual Behavior | 1993 |
Drug delivery concepts for the efficacious prevention of foreign-body infections.
Topics: Ciprofloxacin; Drug Carriers; Erythromycin; Floxacillin; Microbial Sensitivity Tests; Oxacillin; Polyurethanes; Rifampin; Silicones; Staphylococcus epidermidis | 1996 |
Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biocompatible Materials; Biofilms; Ciprofloxacin; Drug Implants; Floxacillin; Fosfomycin; Gentamicins; Humans; Materials Testing; Microscopy, Electron, Scanning; Polyurethanes; Prostheses and Implants; Prosthesis-Related Infections; Staphylococcal Infections | 1997 |
Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Endocarditis, Bacterial; Floxacillin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
The relationship between the use of flucloxacillin, vancomycin, aminoglycosides and ciprofloxacin and the susceptibility patterns of coagulase-negative staphylococci recovered from blood cultures.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Coagulase; Drug Resistance, Microbial; Floxacillin; Humans; Microbial Sensitivity Tests; Penicillins; Sepsis; Streptococcal Infections; Streptococcus; Vancomycin | 1997 |
Cervical discitis in a patient with an oesophageal stent for carcinoma.
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Cervical Vertebrae; Ciprofloxacin; Drug Therapy, Combination; Esophageal Neoplasms; Female; Floxacillin; Humans; Laser Therapy; Magnetic Resonance Imaging; Spondylitis; Stents | 2002 |
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Floxacillin; Fluoroquinolones; Infusions, Intravenous; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Streptococcal Infections; Vancomycin; Viridans Streptococci | 2004 |
Early interventions in CF.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bronchoalveolar Lavage Fluid; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosis; Floxacillin; Humans; Infant; Neutrophils; Pseudomonas Infections; Staphylococcal Infections | 2004 |
Beta-lactam antibiotic-induced release of lipoteichoic acid from Staphylococcus aureus leads to activation of neutrophil granulocytes.
Topics: Apoptosis; Cells, Cultured; Ciprofloxacin; Floxacillin; Humans; Lipopolysaccharides; Monobactams; Neutrophil Activation; Neutrophils; Staphylococcus aureus; Teichoic Acids | 2006 |
Five day antibiotic prophylaxis for major lower limb amputation reduces wound infection rates and the length of in-hospital stay.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; England; Female; Floxacillin; Gentamicins; Humans; Length of Stay; Lower Extremity; Male; Medical Audit; Metronidazole; Middle Aged; Prospective Studies; Reoperation; Retrospective Studies; Surgical Wound Infection; Treatment Outcome; Vancomycin | 2008 |
An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacteria; Bandages; Biofilms; Ciprofloxacin; Floxacillin; Humans; Microbial Sensitivity Tests; Microscopy; Microscopy, Electron, Scanning; Povidone-Iodine; Pseudomonas; Silver; Staphylococcus; Wound Infection | 2010 |
H1N1 vaccination: expect the unexpected.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Clostridium Infections; Clostridium septicum; Female; Floxacillin; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Shock, Septic | 2011 |
Recent outbreak of cutaneous anthrax in Bangladesh: clinico-demographic profile and treatment outcome of cases attended at Rajshahi Medical College Hospital.
Topics: Adolescent; Adult; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bangladesh; Cattle; Child; Child, Preschool; Ciprofloxacin; Disease Outbreaks; Drug Combinations; Female; Floxacillin; Goats; Humans; Male; Meat; Middle Aged; Skin; Skin Diseases, Bacterial; Social Class; Treatment Outcome | 2012 |
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
Implications of Antimicrobial Combinations in Complex Wound Biofilms Containing Fungi.
Topics: Anti-Bacterial Agents; Antifungal Agents; Biofilms; Candida albicans; Ciprofloxacin; Diabetic Foot; Floxacillin; Fluconazole; Foot Ulcer; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 2017 |
Oral antimicrobial agents in patients with short bowel syndrome: worth a try!
Topics: Administration, Oral; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Female; Floxacillin; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Short Bowel Syndrome | 2023 |